eBehandling - Health and Work for Patients in Specialist Mental Health Care
1 other identifier
interventional
400
1 country
9
Brief Summary
Mental health problems and disorders affect one in every five amongst the working- age adults in the countries of the Organization for Economic Cooperation and Development. This constitutes a major public health challenge that also has large implications for work participation and productivity. Major depression and anxiety are the most prevalent of the mental disorders and are therefore named common mental disorders (CMD). CMD have become a major cause of work absenteeism, with 30% of all sick leave in Norway being due to CMDs in 2024. Early interventions addressing psychological aspects and vocational challenges related to work have shown a positive effect on return to work. Therefore, finding ways to increase availability and reduce barriers to evidence-based treatments seems a viable route to reducing mental health's impact on sick leave and absenteeism. Research show that improvement in symptoms from ordinary psychotherapy has little impact on sick-leave. The same results have been found for internet-based cognitive therapy (ICBT). One of the challenges in specialised mental health care is that the work focus has been an additive or extended part of the treatment, not integrated in the treatment itself. Several studies have been conducted on psychological treatments that specifically target return to work for people with CMDs. Systematic reviews have shown that work-focused therapy has a small, but significant effect over treatment as usual on return to work and finds that 20% more workers in the intervention groups had returned to work, compared to control groups. The availability of traditional therapy is scarce and there is an need for new effective ways of delivery. internet-based cognitive therapy has been shown to be as effective as traditional therapy in many systematic reviews and meta analysis and seems a good approach to reach the goal of increasing availability. To account for the heterogene group of people on sick leave the investigators have created a transdiagnostic, work-focused internet-based cognitive behaviloural therapy program. This study aims is to is to investigate the utility and use of this treatment program for patients with common mental health disorders on sick leave or work assessment allowance. This includes the user experience of participation and experienced utility of the treatment program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable anxiety
Started Dec 2024
Longer than P75 for not_applicable anxiety
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 8, 2024
CompletedFirst Posted
Study publicly available on registry
August 23, 2024
CompletedStudy Start
First participant enrolled
December 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2028
April 23, 2026
April 1, 2026
2.3 years
July 8, 2024
April 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Degree of Sickleave
Self-reported degree of sick leave (percentage)
baseline, 6 weeks, 12 weeks, 6 months and 12 months
Return to Work Self-efficacy 11
11-item questionnaire measuring an individual's confidence in their ability to work and perform work tasks. Items are scored on a scale from 1 ("Totally disagree") to 6 ("Totally agree"). Items 2 and 6 are reversed.
baseline, 6 weeks, 12 weeks, 6 months and 12 months
Secondary Outcomes (6)
Generalized Anxiety Disorder-7
baseline, 6 weeks, 12 weeks, 6 months and 12 months
Patient Health Questionnaire-9
baseline, 6 weeks, 12 weeks, 6 months and 12 months
The Work and Social Adjustment Scale
baseline, 6 weeks, 12 weeks, 6 months and 12 months
CORE-OM
baseline, 6 weeks, 12 weeks, 6 months and 12 months
CORE-10
at 2, 4, 8 and 10 weeks
- +1 more secondary outcomes
Other Outcomes (2)
Credibility Rating Scale
baseline, 6 weeks and 12 weeks
Montgomery and Åsberg Depression Rating Scale
baseline and every week for 12 weeks (until the end of the treatment program)
Study Arms (1)
Digital transdiagnostic work-focused CBT treatment program
EXPERIMENTALdigital transdiagnostic work-focused CBT treatment program for patients with common mental health disorders on sick leave or work assessment allowance
Interventions
Transdiagnostic, work-focused Cognitive Behavioural Therapy focuses on core mechanisms that creates and maintain illness in depression and anxiety. Namely reducing avoidance and/or suppression of unwanted thoughts, avoidance of meaningful activity and increase cognitive flexibility while under psychological stress.
Eligibility Criteria
You may qualify if:
- being an outpatient in specialised mental health care service,
- above 18 years old,
- full or graded sick leave, or on work assessment allowance
- primary diagnosis of F30 - F40 (ICD-10),
- currently employed.
You may not qualify if:
- ongoing psychotic disorder and/or mania,
- ongoing substance abuse, incl. sedative medications,
- ongoing episode of major depression,
- organic brain disease,
- severe reading and writing difficulties.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Solli Distriktspsykiatriske Senterlead
- Sykehuset Innlandet HFcollaborator
- Sykehuset Ostfoldcollaborator
- Sykehuset i Vestfold HFcollaborator
- University Hospital, Akercollaborator
- Helse Fonnacollaborator
- Helse Bergen Hospital Trustcollaborator
- Vestre Viken Hospital Trustcollaborator
- Macquarie University, Australiacollaborator
- Diakonhjemmet Hospitalcollaborator
- Haukeland University Hospitalcollaborator
Study Sites (9)
Sykehuset Vestre Viken
Oslo, Bærum, 1346, Norway
Sykehuset Innlandet
Lillehammer, Innlandet, 2609, Norway
Vinderen DPS
Oslo, Oslo, 0373, Norway
AHus DPS Grorudalen
Oslo, Oslo, 1067, Norway
Sykehuset i Vestfold
Tønsberg, Vestfold, 3103, Norway
University of Bergen
Bergen, Vestland, 5007, Norway
Bjørgvin DPS (Helse Bergen)
Bergen, Vestland, 5113, Norway
Solli DPS
Bergen, Vestland, 5227, Norway
Sykehuset i Østfold
Fredrikstad, Østfold fylke, 1603, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Pål William Wallace, PhD
Solli DPS
- STUDY CHAIR
Kristine Sirevåg, MSc
Solli DPS
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 8, 2024
First Posted
August 23, 2024
Study Start
December 1, 2024
Primary Completion (Estimated)
April 1, 2027
Study Completion (Estimated)
August 1, 2028
Last Updated
April 23, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share